Objetivo: Estimar la proporción de sujetos con diabetes mellitus tipo 2 (DMT2) que alcanzan la meta terapéutica para HbA1C un año después del diagnóstico (control metabólico temprano). Métodos: Revisión retrospectiva de historias clínicas de adultos atendidos en 16 centros médicos distribuidos en nueve ciudades peruanas. Se incluyeron pacientes que recibieron un diagnóstico inicial de DMT2 y tuvieron al menos un año de seguimiento. Se consideraron las metas metabólicas definidas en los estándares ADA 2018. Resultados: Se incluyeron 457 sujetos (53,03% mujeres). Cuando fueron diagnosticados, la edad media fue de 55,75 años (DE ± 12,92), la media de HbA1C fue de 9,10% (DE ± 2,28). Hubo diagnóstico concomitante de hipertensión arterial o de dislipidemia en 27,13% y 52,40%, respectivamente. Al año de seguimiento, 57,76% de los sujetos alcanzó la meta de HbA1C (<7,0%). El...

Objective: To estimate the rate of subjects with type 2 diabetes mellitus (T2DM) who reach the therapy goal for HbA1C one year after diagnosis (early metabolic control). Methods: This was a retrospective study reviewing clinical records of adults who came to sixteen health centers distributed in nine Peruvian cities. Patients who received an initial T2DM diagnosis and who had at least one-year follow-up were included. Metabolic goals set in ADA 29018 standards were considered.     Results: Four hundred and fifty-seven subjects (53,03% female) were included. When diagnosed, their mean age was 55,75 years (standard deviation [SD]: ± 12,92), and mean HbA1C value was 9,10% (SD: ± 2,28). Concomitant diagnosis including high blood pressure or dyslipidemia were found in 27,13% and 52,40% of all subjects, respectively. After one-year follow-up, 57,76% of all subjects achieved th...

Objective: To estimate the rate of subjects with type 2 diabetes mellitus (T2DM) who reach the therapy goal for HbA1C one year after diagnosis (early metabolic control). Methods: This was a retrospective study reviewing clinical records of adults who came to sixteen health centers distributed in nine Peruvian cities. Patients who received an initial T2DM diagnosis and who had at least one-year follow-up were included. Metabolic goals set in ADA 29018 standards were considered.     Results: Four hundred and fifty-seven subjects (53,03% female) were included. When diagnosed, their mean age was 55,75 years (standard deviation [SD]: ± 12,92), and mean HbA1C value was 9,10% (SD: ± 2,28). Concomitant diagnosis including high blood pressure or dyslipidemia were found in 27,13% and 52,40% of all subjects, respectively. After one-year follow-up, 57,76% of all subjects achieved th...